These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27789146)

  • 1. Rotavirus, vaccine failure or diagnostic error?
    Lopez-Lacort M; Collado S; Díez-Gandía A; Díez-Domingo J
    Vaccine; 2016 Nov; 34(48):5912-5915. PubMed ID: 27789146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia.
    Beres LK; Tate JE; Njobvu L; Chibwe B; Rudd C; Guffey MB; Stringer JS; Parashar UD; Chilengi R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S175-82. PubMed ID: 27059353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
    Doll MK; Buckeridge DL; Morrison KT; Gagneur A; Tapiero B; Charest H; Quach C
    Vaccine; 2015 Dec; 33(51):7307-7314. PubMed ID: 26546262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatio-temporal impact of self-financed rotavirus vaccination on rotavirus and acute gastroenteritis hospitalisations in the Valencia region, Spain.
    López-Lacort M; Orrico-Sánchez A; Martínez-Beneito MÁ; Muñoz-Quiles C; Díez-Domingo J
    BMC Infect Dis; 2020 Sep; 20(1):656. PubMed ID: 32894071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
    Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP
    Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
    Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
    Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of rotavirus vaccines against hospitalisations in Japan.
    Fujii Y; Noguchi A; Miura S; Ishii H; Nakagomi T; Nakagomi O; Takahashi T
    BMC Pediatr; 2017 Jul; 17(1):156. PubMed ID: 28693503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel.
    Muhsen K; Rubenstein U; Kassem E; Goren S; Schachter Y; Kremer A; Shulman LM; Ephros M; Cohen D
    Hum Vaccin Immunother; 2015; 11(10):2475-82. PubMed ID: 26212174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study.
    Gastañaduy PA; Steenhoff AP; Mokomane M; Esona MD; Bowen MD; Jibril H; Pernica JM; Mazhani L; Smieja M; Tate JE; Parashar UD; Goldfarb DM
    Clin Infect Dis; 2016 May; 62 Suppl 2():S161-7. PubMed ID: 27059351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.
    Ali Z; Harastani H; Hammadi M; Reslan L; Ghanem S; Hajar F; Sabra A; Haidar A; Inati A; Rajab M; Fakhouri H; Ghanem B; Baasiri G; Gerbaka B; Zaraket H; Matar GM; Dbaibo G
    PLoS One; 2016; 11(8):e0161345. PubMed ID: 27571515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal Mass Vaccination Against Rotavirus: Indirect Effects on Rotavirus Infections in Neonates and Unvaccinated Young Infants Not Eligible for Vaccination.
    Prelog M; Gorth P; Zwazl I; Kleines M; Streng A; Zlamy M; Heinz-Erian P; Wiedermann U
    J Infect Dis; 2016 Aug; 214(4):546-55. PubMed ID: 27190178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating rotavirus vaccine effectiveness in Japan using a screening method.
    Araki K; Hara M; Sakanishi Y; Shimanoe C; Nishida Y; Matsuo M; Tanaka K
    Hum Vaccin Immunother; 2016 May; 12(5):1244-9. PubMed ID: 26680277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.
    Adlhoch C; Hoehne M; Littmann M; Marques AM; Lerche A; Dehnert M; Eckmanns T; Wichmann O; Koch J
    Pediatr Infect Dis J; 2013 Feb; 32(2):e82-9. PubMed ID: 23334342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh.
    Feller AJ; Zaman K; Lewis KD; Hossain I; Yunus M; Sack DA
    Vaccine; 2012 Apr; 30 Suppl 1():A101-5. PubMed ID: 22520118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus vaccination effectiveness: a case-case study in the EDICS project, Castellón (Spain).
    Bellido-Blasco JB; Sabater-Vidal S; Salvador-Ribera Mdel M; Arnedo-Pena A; Tirado-Balaguer MD; Meseguer-Ferrer N; Silvestre-Silvestre E; Romeu-García MÀ; Herrero-Carot C; Moreno-Muñoz MR
    Vaccine; 2012 Dec; 30(52):7536-40. PubMed ID: 23103196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Weinberg GA; Hall CB; Chappell J; Curns AT; Wikswo M; Tate JE; Lopman BA; Parashar UD;
    Clin Infect Dis; 2011 Aug; 53(3):245-53. PubMed ID: 21705316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.
    Sáfadi MA; Berezin EN; Munford V; Almeida FJ; de Moraes JC; Pinheiro CF; Racz ML
    Pediatr Infect Dis J; 2010 Nov; 29(11):1019-22. PubMed ID: 20543761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
    Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
    Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.